Clinical Trials Directory

Trials / Completed

CompletedNCT00004306

Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10)

Pathogenic Mechanism of Spinocerebellar Ataxia Type 10 (SCA10)

Status
Completed
Phase
Study type
Observational
Enrollment
18 (actual)
Sponsor
Office of Rare Diseases (ORD) · NIH
Sex
All
Age
3 Years
Healthy volunteers
Not accepted

Summary

OBJECTIVES: I. Clinically evaluate members from families with a dominantly inherited ataxia and collect blood, skin and muscle samples for detailed molecular studies. II. Perform detailed clinical evaluations on patients with recessively inherited ataxias.

Detailed description

PROTOCOL OUTLINE: Participants undergo a comprehensive clinical and molecular evaluation. Studies include: neurologic evaluation, including magnetic resonance imaging and nerve conduction studies; ophthalmologic exam; audiologic exam, including auditory brain stem evoked response; DNA extraction from blood, skin and muscle; genotype phenotype correlation. A neuropathologic evaluation is conducted postmortem, when possible.

Conditions

Timeline

Start date
1999-11-01
Primary completion
2009-03-01
Completion
2009-03-01
First posted
1999-10-19
Last updated
2012-03-06

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00004306. Inclusion in this directory is not an endorsement.

Clinical and Molecular Correlations in Spinocerebellar Ataxia Type 10 (SCA10) (NCT00004306) · Clinical Trials Directory